UBS Group AG - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 19 filers reported holding EFFECTOR THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 2.8%.

Quarter-by-quarter ownership
UBS Group AG ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,924
-21.6%
9,874
-53.9%
0.00%
Q1 2023$7,559
-33.1%
21,414
-18.5%
0.00%
Q4 2022$11,293
+25.5%
26,263
+58.6%
0.00%
Q3 2022$9,000
+800.0%
16,558
+11643.3%
0.00%
Q1 2022$1,000
-95.0%
141
-94.1%
0.00%
Q4 2021$20,0002,4010.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,822,114$4,025,0472.06%
Column Group LLC 4,026,224$2,415,3321.60%
OUP Management Co., LLC 1,025,697$615,3161.38%
SECTORAL ASSET MANAGEMENT INC 2,382,644$1,429,3480.28%
Carlyle Group Inc. 4,822,114$2,868,6760.12%
Sea Otter Advisors LLC 263,942$158,3390.09%
Parallel Advisors, LLC 1,693,559$1,015,9660.03%
Sonora Investment Management Group, LLC 125,000$74,9880.01%
Wescott Financial Advisory Group, LLC 30,556$18,3310.00%
Oasis Management Co Ltd. 100,000$59,9900.00%
View complete list of EFFECTOR THERAPEUTICS INC shareholders